tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MESO Stock Latest News

Mesoblast reports Q2 Ryoncil revenue up 66% y/y
The FlyMesoblast reports Q2 Ryoncil revenue up 66% y/y
4d ago
MESO
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
PremiumThe Fly
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
7d ago
MESO
Mesoblast’s U.S. Origin Designation Shields Products from Tariffs
PremiumCompany Announcements
Mesoblast’s U.S. Origin Designation Shields Products from Tariffs
11d ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
15d ago
BNC
MBX
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
PremiumRatings
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
1M ago
MESO
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
1M ago
SU
LIT
Mesoblast’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Mesoblast’s Earnings Call Highlights Growth and Challenges
1M ago
MESO
Mesoblast falls -12.9%
Premium
The Fly
Mesoblast falls -12.9%
1M ago
MESO
Mesoblast falls -12.5%
PremiumThe Fly
Mesoblast falls -12.5%
1M ago
MESO
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
PremiumCompany Announcements
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
1M ago
MESO
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
PremiumThe Fly
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
1M ago
MESO
Mesoblast options imply 11.6% move in share price post-earnings
PremiumThe Fly
Mesoblast options imply 11.6% move in share price post-earnings
1M ago
MESO
Mesoblast downgraded to Hold from Buy at Jefferies
PremiumThe FlyMesoblast downgraded to Hold from Buy at Jefferies
3M ago
MESO
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
Premium
The Fly
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
3M ago
MESO
Mesoblast Announces Cessation of Securities and Capital Adjustments
Premium
Company Announcements
Mesoblast Announces Cessation of Securities and Capital Adjustments
3M ago
6K
MESO
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
PremiumRatings
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
3M ago
MESO
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
PremiumThe Fly
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
4M ago
MESO
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
MESO
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
PremiumThe Fly
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
5M ago
MESO
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
PremiumThe FlyMesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
6M ago
MESO
Mesoblast Updates Securities Status with ASX
Premium
Company Announcements
Mesoblast Updates Securities Status with ASX
6M ago
6K
MESO
Mesoblast Announces Director Securities Changes Following AGM Approval
Premium
Company Announcements
Mesoblast Announces Director Securities Changes Following AGM Approval
6M ago
6K
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >